These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 11871363)

  • 1. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.
    Vincken W; van Noord JA; Greefhorst AP; Bantje TA; Kesten S; Korducki L; Cornelissen PJ;
    Eur Respir J; 2002 Feb; 19(2):209-16. PubMed ID: 11871363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
    Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
    Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009552. PubMed ID: 26391969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
    van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
    Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
    van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
    Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD.
    Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J
    Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
    ZuWallack AR; ZuWallack RL
    Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
    Tashkin D; Kesten S
    Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009285. PubMed ID: 25046211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
    Barr RG; Bourbeau J; Camargo CA; Ram FS
    Thorax; 2006 Oct; 61(10):854-62. PubMed ID: 16844726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.
    Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC
    J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
    Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
    Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.